Response to ‘‘A Claim for Caution in the Use of Promising Bumetanide to Treat Neonatal Seizures’’

Kahle KT , Barnett SM , Sassower KC , et al. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol. 2009;24:572-576.

Kahle KT , Staley KJ The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Neurosurg Focus. 2008; 25:E22.

Dzhala VI , Talos DM , Sdrulla DA , et al. NKCC1 transporter facilitates seizures in the developing brain . Nat Med. 2005;11: 1205-1213.

Dzhala VI , Brumback AC , Staley KJ Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol. 2008;63:222-235.

Nardou R. , Ben-Ari Y. , Khalilov I. Bumetanide, an NKCC1 antagonist, does not prevent formation of epileptogenic focus but blocks epileptic focus seizures in immature rat hippocampus. J Neurophysiol. 2009;101:2878-2888.

Mazarati A. , Shin D. , Sankar R. Bumetanide inhibits rapid kindling in neonatal rats. Epilepsia . 2009;50:2117-2122.

Dzhala VI , Kuchibhotla KV , Glykys JC , et al. Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. J Neurosci. 2010;30:11745-11761.

Wahab A. , Albus K. , Heinemann U. Age- and region-specific effects of anticonvulsants and bumetanide on 4-aminopyridine-induced seizure-like events in immature rat hippocampal-entorhinal cortex slices. Epilepsia. 2011;52:94-103.

Sullivan JE , Witte MK , Yamashita TS , et al. Pharmacokinetics of bumetanide in critically ill infants. Clin Pharmacol Ther. 1996; 60:405-413.

Lopez-Samblas AM , Adams JA , Goldberg RN , et al. The pharmacokinetics of bumetanide in the newborn infant. Biol Neonate. 1997;72:265-272.

Lemonnier E. , Ben-Ari Y. The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects. Acta Paediatr. 2010;99: 1885-1888.

Ben-Ari Y. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci. 2002;3:728-739.

Wang DD , Kriegstein AR Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits [published online ahead of print July 19, 2010]. Cereb Cortex.

Edwards DA , Shah HP , Cao W. , et al. Bumetanide alleviates epileptogenic and neurotoxic effects of sevoflurane in neonatal rat brain. Anesthesiology. 2010;112:567-575.

Brandt C. , Nozadze M. , Heuchert N. , et al. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. J Neurosci. 2010;30:8602-8612.

Bittigau P. , Sifringer M. , Genz K. , et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A. 2002;99:15089-15094.

Ge S. , Goh EL , Sailor KA , et al. GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature. 2006; 439:589-593.

Cancedda L. , Fiumelli H. , Chen K. , et al. Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo. J Neurosci. 2007;27:5224-5235.

Wirrell EC , Armstrong EA , Osman LD , et al. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr Res. 2001;50:445-454.

Auvin S. , Shin D. , Mazarati A. , et al. Inflammation exacerbates seizure-induced injury in the immature brain. Epilepsia. 2007; 48(suppl 5):27-34.

Farwell JR , Lee YJ , Hirtz DG , Sulzbacher SI , et al. Phenobarbital for febrile seizures-effects on intelligence and on seizure recurrence. N Engl J Med. 1990;322:364-369.

Reinisch JM , Sanders SA , Mortensen EL , et al. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA. 1995;274:1518-1525.